Neuronal and Glial differentiation Specialist in the Tissue Engineering Unit

The Institute

The Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence, based in Barcelona, Spain, with more than 400 scientists from 44 countries. The CRG is composed by an interdisciplinary, motivated and creative scientific team which is supported both by a flexible and efficient administration and by high-end and innovative technologies.

In April 2021, the Centre for Genomic Regulation (CRG) received the renewal of the 'HR Excellence in Research ' Award from the European Commission. This is a recognition of the Institute's commitment to developing an HR Strategy for Researchers, designed to bring the practices and procedures in line with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers (Charter and Code).

Please, check out our Recruitment Policy

The role

The desired candidate will generate and characterize human iPS cells from patient samples with specific diseases and will perform differentiation to neurons, astrocytes and oligodendrocytes that will be treated with specific factors/drugs. The candidate will be involved in posterior analyses in collaboration with international labs as part of a consortia. The desired candidate will also help the Tissue Engineering team in the achievement of additional projects/services.

Applicants should be highly motivated, resolutive, methodological with accurate work habits and clear team-building skills. The ideal candidate has a strong ability to multi-task and has a service-oriented mentality.

The position involves working some weekends and holiday days during the year.

The unit

The Tissue Engineering Unit is a technology unit within the Core Technologies Program. The goal of the Tissue Engineering Unit is to provide CRG, PRBB and external researchers with the latest technologies used in the fields of stem cell biology, stem cell differentiation, organoid formation, induced pluripotent stem cells (iPSCs) and CRISPR/Cas9 gene editing. The unit was established 5 years ago to help the research community in performing Stem Cell and Organoids projects and to perform technology development in the above fields.